The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma
- Author
- BEEH, Kai-Michael1 ; KANNIESS, Frank2 ; RENNER, Wolfgang A6 ; WAGNER, Frank3 ; SCHILDER, Cordula4 ; NAUDTS, Ingomar5 ; HAMMANN-HAENNI, Anya6 ; WILLERS, Joerg6 ; STOCKER, Hans6 ; MUELLER, Philipp6 ; BACHMANN, Martin F6
[1] Insaf Respiratory Research Institute, Biebricher Allee 34, Wiesbaden, Germany
[2] KLB Healthresearch Lübeck, Pferdemarkt 6-8, Lübeck, Germany
[3] Charité Research Organisation, Charitéplatz 1, Berlin, Germany
[4] Health Center Schilder, Langensalzer Strasse 8, Eisenach, Germany
[5] Praxis Rodgau, Ludwig-Erhard-Platz 11, Rodgau, Germany
[6] Cytos Biotechnology AG, Wagistrasse 25, Schlieren, Germany - Source
Journal of allergy and clinical immunology. 2013, Vol 131, Num 3, pp 866-874, 9 p ; ref : 44 ref
- CODEN
- JACIBY
- ISSN
- 0091-6749
- Scientific domain
- Dermatology; Immunology, immunopathology, allergology; Pneumology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Persistent allergic asthma Toll-like receptor 9 clinical trial immune modulator virus-like particle
- Keyword (fr)
- Agoniste Allergie Asthme Efficacité traitement Essai clinique Immunologie Immunomodulateur Immunopathologie Particule type viral Récepteur TLR9 Bronchopneumopathie obstructive Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons
- Keyword (en)
- Agonist Allergy Asthma Treatment efficiency Clinical trial Immunology Immunomodulator Immunopathology Virus like particle Toll like receptor 9 Obstructive pulmonary disease Respiratory disease Bronchus disease Lung disease
- Keyword (es)
- Agonista Alergia Asma Eficacia tratamiento Ensayo clínico Inmunología Inmunomodulador Inmunopatología Partícula tipo vírico Receptor TLR9 Enfermedad pulmonar obstructiva Aparato respiratorio patología Bronquio patología Pulmón patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A06 Fundamental immunology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B07 Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11B Chronic obstructive pulmonary disease, asthma
- Discipline
- Fundamental immunology Immunopathology Pulmonology Sarcoidosis. Granulomatosis of undetermined origin. Connective tissue diseases. Vasculitides
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27157169
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.jaci.2012.12.1561 
https://dx.doi.org/10.1016/j.jaci.2012.12.1561
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.jaci.2012.12.1561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Journal of allergy and clinical immunology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. allergy clin. immunol\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"866\";s:8:\"\u0000*\u0000epage\";s:3:\"874\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0091-6749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BEEH\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Kai-Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"KANNIESS, Frank\";i:1;s:18:\"RENNER, Wolfgang A\";i:2;s:13:\"WAGNER, Frank\";i:3;s:17:\"SCHILDER, Cordula\";i:4;s:15:\"NAUDTS, Ingomar\";i:5;s:20:\"HAMMANN-HAENNI, Anya\";i:6;s:14:\"WILLERS, Joerg\";i:7;s:13:\"STOCKER, Hans\";i:8;s:16:\"MUELLER, Philipp\";i:9;s:18:\"BACHMANN, Martin F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACIBY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.jaci.2012.12.1561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Journal of allergy and clinical immunology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. allergy clin. immunol\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"866\";s:8:\"\u0000*\u0000epage\";s:3:\"874\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0091-6749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BEEH\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Kai-Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"KANNIESS, Frank\";i:1;s:18:\"RENNER, Wolfgang A\";i:2;s:13:\"WAGNER, Frank\";i:3;s:17:\"SCHILDER, Cordula\";i:4;s:15:\"NAUDTS, Ingomar\";i:5;s:20:\"HAMMANN-HAENNI, Anya\";i:6;s:14:\"WILLERS, Joerg\";i:7;s:13:\"STOCKER, Hans\";i:8;s:16:\"MUELLER, Philipp\";i:9;s:18:\"BACHMANN, Martin F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACIBY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.jaci.2012.12.1561\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.jaci.2012.12.1561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Journal of allergy and clinical immunology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. allergy clin. immunol\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"866\";s:8:\"\u0000*\u0000epage\";s:3:\"874\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0091-6749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BEEH\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Kai-Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"KANNIESS, Frank\";i:1;s:18:\"RENNER, Wolfgang A\";i:2;s:13:\"WAGNER, Frank\";i:3;s:17:\"SCHILDER, Cordula\";i:4;s:15:\"NAUDTS, Ingomar\";i:5;s:20:\"HAMMANN-HAENNI, Anya\";i:6;s:14:\"WILLERS, Joerg\";i:7;s:13:\"STOCKER, Hans\";i:8;s:16:\"MUELLER, Philipp\";i:9;s:18:\"BACHMANN, Martin F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACIBY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.jaci.2012.12.1561\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:9:\"\u0000*\u0000jtitle\";s:42:\"Journal of allergy and clinical immunology\";s:9:\"\u0000*\u0000stitle\";s:24:\"J. allergy clin. immunol\";s:7:\"\u0000*\u0000date\";s:4:\"2013\";s:9:\"\u0000*\u0000volume\";s:3:\"131\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"866\";s:8:\"\u0000*\u0000epage\";s:3:\"874\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0091-6749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"BEEH\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Kai-Michael\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:15:\"KANNIESS, Frank\";i:1;s:18:\"RENNER, Wolfgang A\";i:2;s:13:\"WAGNER, Frank\";i:3;s:17:\"SCHILDER, Cordula\";i:4;s:15:\"NAUDTS, Ingomar\";i:5;s:20:\"HAMMANN-HAENNI, Anya\";i:6;s:14:\"WILLERS, Joerg\";i:7;s:13:\"STOCKER, Hans\";i:8;s:16:\"MUELLER, Philipp\";i:9;s:18:\"BACHMANN, Martin F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JACIBY\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:83:\"The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
